Clinical Trials Browser

OTHER × Observational × aflutinib × Clear all

NCT06352502 2024-04-08

An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis

EGF-R Positive Non-Small Cell Lung Cancer

NCT06117644 2023-11-07

The Efficacy of Double-dose Furmonertinib in the Treatment of Patients With Slow Osimertinib-resistant NSCLC

Not yet recruiting

Carcinoma, Non-Small-Cell Lung